POST COVID-19 IMPACT ON INFLUENZA VACCINE MARKET - GLOBAL FORECAST TO 2025
Get in-depth analysis of how COVID-19 is impacting the Influenza Vaccine Market. We’ve been tracking the direct impact of COVID-19 on Influenza Vaccine Market, as well as the indirect impact from other industries. The report will incorporate these insights.
Key and emerging market players include AstraZeneca (UK), GlaxoSmithKline PLC (UK), Sanofi (France), Abbott Laboratories (US), Seqirus (UK), Hualan Biological Engineering Inc. (China), Mitsubishi Tanabe Pharma (Japan), Serum Institute of India Pvt. Ltd (India), and Mylan NV (US), Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd, Gamma Vaccines Pty Ltd., Merck & Co., Inc. (Merck Sharp & Dohme Corp.), Novartis AG, Pfizer, Inc., and Sinovac Biotech Ltd.
The main objective of the report is to define, describe, and forecast the global Influenza Vaccine market. The report provides detailed information regarding the major factors influencing the growth of the predictive analytics market (drivers, restraints, opportunities, and industry-specific challenges).
The report aims to strategically analyze micro markets with respect to the individual growth trends, prospects, and contributions to the total market. The report attempts to forecast the market size with respect to the 5 main regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. The report strategically profiles key players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as partnerships, collaborations, and agreements; mergers and acquisitions; new product launches and new product developments; and Research and Development (R&D) activities in the market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as dietary supplement manufacturers, distributors and dealers, customers and policy makers. The study would help them to identify which market segments should be targeted over the coming years in order to strategize investments and capitalize on the growth opportunities in the market.
Scope of the Report:
Influenza Vaccine Market, By Vaccine Type
- Nasal Spray
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Attractive Market Opportunities in the Global Influenza Vaccine Market
4.2 Influenza Vaccine Market, By Vaccine Type
4.3 Influenza Vaccine Market, By Type
4.4 Influenza Vaccine Market, By Technology
4.5 Influenza Vaccine Market, By Age Group
4.6 Influenza Vaccine Market, By Route of Administration
4.7 Influenza Vaccine Market, By Region
5 Market Overview and Industry Trends
5.2 Market Dynamics
6. Influenza Vaccine Market, By Vaccine Type
7 Influenza Vaccine Market, By Type
8 Influenza Vaccine Market, By Technology
9 Influenza Vaccine Market, By Age Group
10.3 Nasal Spray
11 Influenza Vaccine Market, By Region
11.2 North America
11.4 Asia Pacific
11.5 Middle East and Africa
11.6 Latin America
12 Competitive Landscape
13 Company Profiles
(Business Overview, Products & Services, Key Developments, Financials, SWOT Analysis)*
13.2 GlaxoSmithKline PLC
13.4 Abbott Laboratories
13.6 Hualan Biological Engineering Inc.
13.7 Mitsubishi Tanabe Pharma
13.8 Serum Institute of India Pvt. Ltd
13.9 Mylan NV
13.11 CSL Limited
13.12 Emergent BioSolutions
13.13 F. Hoffmann-La Roche Ltd
13.14 Gamma Vaccines Pty Ltd.
13.15 Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
13.16 Novartis AG
13.17 Pfizer, Inc.
13.18 Sinovac Biotech Ltd.
*Details Might Not Be Captured in Case of Unlisted Companies.